What you need to knowOffer four classes of medicine (angiotensin converting enzyme inhibitors, beta blockers, mineralocorticoid receptor antagonists, […]
Scientists and physicians around the world were horrified when the US Environmental Protection Agency (EPA) announced its plan […]
NICE recommends non‑hormonal therapy for moderate to severe vasomotor symptoms
BE BOLD trial shows bimekizumab outperforms risankizumab at Week 16
Senior midwife Donna Ockenden will lead the independent review into maternity and neonatal services at Leeds Teaching Hospitals […]
A comprehensive public health approach is needed to study the impact of digital technology on health
Barely a day goes by without media and political concern about the impact of digital technology on health, […]
Abbasi scrutinises the word “hallucination.”1 In applying it to an artificial intelligence (AI) chatbot’s invented text—especially the bogus […]
Landmark changes allowing resident doctors and newly appointed consultants to vote in key Royal College of Physicians (RCP) […]
On 26 January 2026 the UK lost its measles elimination status,1 which requires at least 95% of a […]
Early data show favourable safety and sustained target engagement for oral EP4 receptor antagonist